AI has never had more attention. But the real transformation begins when it moves from promise to practice. In this episode of Early Signs, Prashant Warier, Co-founder & CEO of Qure.ai, sits down with Dr. Amit Kakar, Managing Partner, Head of Novo Holdings Asia, for a wide-ranging conversation on what it will take for AI to create meaningful impact in healthcare. Despite the extraordinary attention around AI, Amit believes its adoption across healthcare is still only at the “tip of the iceberg.” The opportunity now is to move beyond the hype and embed AI into the systems, workflows and decisions where it can make a real difference. From radiologists working alongside AI to technology becoming almost invisible in clinical workflows, they explore what adoption could actually look like. They also get into how investors are thinking about AI companies, why Amit wouldn’t invest in a “pure AI” company, and where AI can create real value. The conversation looks further ahead too to digital twins that could put a person’s entire health history at their fingertips, faster drug discovery and clinical trials, and just how far AI could ultimately take human health. In this episode:<ul><li>Why AI adoption still lags behind the hype</li><li>What happens to radiologists in an AI-enabled world</li><li>Why the best healthcare AI could become almost invisible</li><li>Why Amit wouldn’t invest in a “pure AI” company</li><li>What healthcare investors are looking for in the AI era</li><li>How digital twins could transform patient care</li><li>How AI could accelerate drug discovery and clinical trials</li><li>What healthcare could look like by 2050</li></ul> Guest:Dr. Amit KakarManaging Partner, Head of Novo Holdings Asia Host:Prashant WarierCo-Founder & CEO, Qure.ai

AI has never had more attention. But the real transformation begins when it moves from promise to practice.In this episode of Early Signs, Prashant Warier, Co-founder & CEO of Qure.ai, sits down with Dr. Amit Kakar, Managing Partner, Head of Novo Holdings Asia, for a wide-ranging conversation on what it will take for AI to create meaningful impact in healthcare.Despite the extraordinary attention around AI, Amit believes its adoption across healthcare is still only at the “tip of the iceberg.” The opportunity now is to move beyond the hype and embed AI into the systems, workflows and decisions where it can make a real difference.From radiologists working alongside AI to technology becoming almost invisible in clinical workflows, they explore what adoption could actually look like. They also get into how investors are thinking about AI companies, why Amit wouldn’t invest in a “pure AI” company, and where AI can create real value.The conversation looks further ahead too to digital twins that could put a person’s entire health history at their fingertips, faster drug discovery and clinical trials, and just how far AI could ultimately take human health.In this episode:Why AI adoption still lags behind the hypeWhat happens to radiologists in an AI-enabled worldWhy the best healthcare AI could become almost invisibleWhy Amit wouldn’t invest in a “pure AI” companyWhat healthcare investors are looking for in the AI eraHow digital twins could transform patient careHow AI could accelerate drug discovery and clinical trialsWhat healthcare could look like by 2050Guest:Dr. Amit KakarManaging Partner, Head of Novo Holdings AsiaHost:Prashant WarierCo-Founder & CEO, Qure.ai

Early Signs Podcast

AI Wont Change Healthcare Until We Actually Use It | Early Signs Ep.4 with Dr. Amit Kakar

AI is rapidly changing how we work, live, and make decisions. But what happens when that transformation reaches healthcare and ultimately, the patient? In this episode of The Early Signs Podcast, our Co-Founder and CEO Prashant Warier sits down with Dr. Sunil Verma, SVP & Global Head of Oncology at AstraZeneca, for a wide-ranging conversation on what AI could mean for the future of healthcare and humanity. From giving patients a stronger voice in their own care to transforming clinical decision-making, drug discovery, and healthcare delivery, Dr. Verma explores both the possibilities and the challenges that lie ahead. He believes the next three years could define the incredible opportunity AI has to unleash. Together, they explore: * How AI could give patients a stronger voice in their own care* Why treatment decisions may become increasingly complex as options multiply* The promise and limitations of AI in drug discovery and clinical trials* What it could take to move from "sick care" to more proactive, continuous care* How organisations can build AI literacy and adoption* The ethical guardrails needed as AI becomes more powerful If you work in healthcare, life sciences, technology, or are simply curious about where AI is headed—this conversation offers a look at what comes next. Guest:Dr. Sunil VermaSVP & Global Head, Oncology Franchise, AstraZeneca Host:Prashant WarierCo-Founder & CEO, Qure.ai

AI is rapidly changing how we work, live, and make decisions. But what happens when that transformation reaches healthcare and ultimately, the patient?In this episode of The Early Signs Podcast, our Co-Founder and CEO Prashant Warier sits down with Dr. Sunil Verma, SVP & Global Head of Oncology at AstraZeneca, for a wide-ranging conversation on what AI could mean for the future of healthcare and humanity.From giving patients a stronger voice in their own care to transforming clinical decision-making, drug discovery, and healthcare delivery, Dr. Verma explores both the possibilities and the challenges that lie ahead.He believes the next three years could define the incredible opportunity AI has to unleash.Together, they explore:* How AI could give patients a stronger voice in their own care* Why treatment decisions may become increasingly complex as options multiply* The promise and limitations of AI in drug discovery and clinical trials* What it could take to move from "sick care" to more proactive, continuous care* How organisations can build AI literacy and adoption* The ethical guardrails needed as AI becomes more powerfulIf you work in healthcare, life sciences, technology, or are simply curious about where AI is headed—this conversation offers a look at what comes next.Guest:Dr. Sunil VermaSVP & Global Head, Oncology Franchise, AstraZenecaHost:Prashant WarierCo-Founder & CEO, Qure.ai

Is AI the Biggest Revolution in Healthcare? | Early Signs Podcast with Dr. Sunil Verma | Episode 3

Everyone is talking about AI in healthcare but very few are talking about what it actually takes to build it. In Episode 2 of Early Signs Podcast, Qure.ai Co-founder & CEO Prashant Warier sits down with Dr. Amit Gupta, Executive Vice Chair of Radiology at University Hospitals Cleveland Medical Center and Professor at Case Western Reserve University. But this isn't just another conversation about AI, It's a conversation about clinicians becoming builders. Dr. Amit Gupta shares how he's using AI to build tools for radiologists, why workflows matter more than algorithms, what healthcare gets wrong about AI adoption, and how partnerships between clinicians and technology companies can help bring earlier diagnosis into everyday clinical practice. Whether you're a clinician, researcher, startup founder, engineer or simply curious about the future of medicine, this episode offers a practical look at where healthcare AI is really headed. Guest:Dr. Amit GuptaThoracic Radiologist; Imaging Informatics Expert; Division Chief of Cardiothoracic Imaging & Executive Vice Chair of Radiology, University Hospitals Cleveland Medical Center   Host:Prashant WarierCo-Founder & CEO, Qure.ai

Everyone is talking about AI in healthcare but very few are talking about what it actually takes to build it.In Episode 2 of Early Signs Podcast, Qure.ai Co-founder & CEO Prashant Warier sits down with Dr. Amit Gupta, Executive Vice Chair of Radiology at University Hospitals Cleveland Medical Center and Professor at Case Western Reserve University.But this isn't just another conversation about AI, It's a conversation about clinicians becoming builders.Dr. Amit Gupta shares how he's using AI to build tools for radiologists, why workflows matter more than algorithms, what healthcare gets wrong about AI adoption, and how partnerships between clinicians and technology companies can help bring earlier diagnosis into everyday clinical practice.Whether you're a clinician, researcher, startup founder, engineer or simply curious about the future of medicine, this episode offers a practical look at where healthcare AI is really headed.Guest:Dr. Amit GuptaThoracic Radiologist; Imaging Informatics Expert; Division Chief of Cardiothoracic Imaging & Executive Vice Chair of Radiology, University Hospitals Cleveland Medical Center  Host:Prashant WarierCo-Founder & CEO, Qure.ai

AI Isn't Replacing Doctors It's Creating Better Ones? | Early Signs Podcast with Dr. Amit Gupta | Episode 2

What could the future of healthcare look like when governments, healthcare providers, and technology leaders work together to expand access to cost-effective healthcare solutions?  In the first episode of Early Signs, Prashant Warier, Co-Founder & CEO of Qure.ai, speaks with Dr. Neil Buddy Shah, CEO of the Clinton Health Access Initiative (CHAI) and Chair of Anthropic's Long-Term Benefit Trust, on global health equity, AI in healthcare policy, data-driven global health infrastructure, and more.  The conversation explores how countries can use AI to strengthen universal health coverage, support frontline health workers, improve access to diagnostics, and make better use of existing resources. The discussion also examines the role of government leadership, regulatory safeguards, patient safety, and public trust in shaping the future of healthcare. From point-of-care diagnostics and community-based care models to national health intelligence systems, this episode looks at how technology can help countries accelerate progress toward better health outcomes while working within real-world workforce and infrastructure constraints. Listen to the full episode of our podcast today. Guest:Dr. Neil Buddy ShahCEO, Clinton Health Access Initiative (CHAI);Chair, Anthropic's Long-Term Benefit Trust Host:Prashant WarierCo-Founder & CEO, Qure.ai

What could the future of healthcare look like when governments, healthcare providers, and technology leaders work together to expand access to cost-effective healthcare solutions? In the first episode of Early Signs, Prashant Warier, Co-Founder & CEO of Qure.ai, speaks with Dr. Neil Buddy Shah, CEO of the Clinton Health Access Initiative (CHAI) and Chair of Anthropic's Long-Term Benefit Trust, on global health equity, AI in healthcare policy, data-driven global health infrastructure, and more. The conversation explores how countries can use AI to strengthen universal health coverage, support frontline health workers, improve access to diagnostics, and make better use of existing resources. The discussion also examines the role of government leadership, regulatory safeguards, patient safety, and public trust in shaping the future of healthcare.From point-of-care diagnostics and community-based care models to national health intelligence systems, this episode looks at how technology can help countries accelerate progress toward better health outcomes while working within real-world workforce and infrastructure constraints.Listen to the full episode of our podcast today.Guest:Dr. Neil Buddy ShahCEO, Clinton Health Access Initiative (CHAI);Chair, Anthropic's Long-Term Benefit TrustHost:Prashant WarierCo-Founder & CEO, Qure.ai

The Future of AI in Healthcare | Early Signs Podcast with Dr. Neil Buddy Shah | Episode 1

Early Signs is Qure.ai's declaration that the most important conversations in AI and healthcare happen here. Not at the panel. Not in the press release. In the room with Prashant, a founder who has deployed AI diagnostics across 107 countries and the clinicians, scientists, and entrepreneurs who are doing the work that will define the next decade of healthcare.

Early Signs is Qure.ai's declaration that the most important conversations in AI and healthcare happen here. Not at the panel. Not in the press release. In the room with Prashant, a founder who has deployed AI diagnostics across 107 countries and the clinicians, scientists, and entrepreneurs who are doing the work that will define the next decade of healthcare.

hubhopper

Early Signs Podcast

hubhopper